Ms. Amanda Burkardt has over 15 years of experience commercializing technology, consulting, and scientific research both domestically and internationally. She earned her bachelor’s degree in animal science and her master’s degree in molecular biology from Oklahoma State University where she focused on developing alternatives to antibiotics. From here, she spun off a company based on her master’s research in parallel to getting a MBA and master’s of information technology from Oklahoma University. Through these experiences, Ms. Burkardt formed a consulting firm that advised investors, scientists, entrepreneurs, universities, and large corporations in evaluating technologies for start-up opportunities, as well as developmental, partnership and commercialization strategies. She has worked with clients around the world from large-multinational Fortune 500 companies to investor groups and governments. She is frequently involved in industry-wide speaker series, judging panels, newsletters, articles, podcasts, webinars and reports. At PHIOGEN, Ms. Burkardt leads the company’s commercialization efforts to fulfill its mission of creating next-generation phage solutions for humanity's most deadly bacterial infections.